Detalhe da pesquisa
1.
Caudal type homeobox 2 expression induced by leukocytapheresis might be associated with mucosal healing in ulcerative colitis.
J Gastroenterol Hepatol
; 32(5): 1032-1039, 2017 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-27862316
2.
Factors associated with treatment outcome, and long-term prognosis of patients with ulcerative colitis undergoing selective depletion of myeloid lineage leucocytes: a prospective multicenter study.
Cytotherapy
; 17(5): 680-8, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25804800
3.
Crohn's disease complicated by hepatitis B virus successfully treated with the use of adsorptive depletion of myeloid lineage leucocytes to suppress inflammatory cytokine profile.
Cytotherapy
; 16(6): 821-5, 2014 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-24713332
4.
Multicenter prospective study for clinical and endoscopic efficacies of leukocytapheresis therapy in patients with ulcerative colitis.
Scand J Gastroenterol
; 48(4): 412-8, 2013 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-23356660
5.
Looking for predictive factors of clinical response to adsorptive granulocyte and monocyte apheresis in patients with ulcerative colitis: markers of response to GMA.
BMC Gastroenterol
; 13: 27, 2013 Feb 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-23399416
6.
Current status and future perspectives of leukocytapheresis for inflammatory bowel disease.
J Gastroenterol Hepatol
; 27(6): 997-1003, 2012 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-22414250
7.
Placebo controlled evaluation of Xilei San, a herbal preparation in patients with intractable ulcerative proctitis.
J Gastroenterol Hepatol
; 27(12): 1808-15, 2012 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-22775479
8.
The CD4+CD28null and the regulatory CD4+CD25High T-cell phenotypes in patients with ulcerative colitis during active and quiescent disease, and following colectomy.
Cytokine
; 56(2): 466-70, 2011 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-21802311
9.
GC/MS-based profiling of amino acids and TCA cycle-related molecules in ulcerative colitis.
Inflamm Res
; 60(9): 831-40, 2011 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-21523508
10.
Effect and safety of granulocyte-monocyte adsorption apheresis for patients with ulcerative colitis positive for cytomegalovirus in comparison with immunosuppressants.
Digestion
; 84(1): 3-9, 2011.
Artigo
em Inglês
| MEDLINE | ID: mdl-21311190
11.
Optimal apheresis treatment volume for the efficacy and safety of leukocytapheresis with Cellsorba in patients with active ulcerative colitis.
J Clin Apher
; 26(6): 326-31, 2011 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-22083887
12.
Selective depletion of peripheral granulocyte/monocyte enhances the efficacy of scheduled maintenance infliximab in Crohn's disease.
J Clin Apher
; 25(4): 226-8, 2010.
Artigo
em Inglês
| MEDLINE | ID: mdl-20544712
13.
An open-label prospective randomized multicenter study shows very rapid remission of ulcerative colitis by intensive granulocyte and monocyte adsorptive apheresis as compared with routine weekly treatment.
Am J Gastroenterol
; 104(12): 2990-5, 2009 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-19724269
14.
Hyperthermic stimulation of blood increases the immunological effects of granulocyte and monocyte adsorption in vitro: relevance to extracorporeal immunomodulation.
Transfus Apher Sci
; 39(2): 129-35, 2008 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-18762459
15.
Cytapheresis as a Non-Pharmacological Therapy for Inflammatory Bowel Disease.
Transfus Med Hemother
; 35(1): 18-23, 2008.
Artigo
em Inglês
| MEDLINE | ID: mdl-21547106
16.
Therapeutic leukocytapheresis for inflammatory bowel disease.
Transfus Apher Sci
; 37(2): 191-200, 2007 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-17974479
17.
Role of leukocytapheresis in the management of inflammatory bowel disease.
Trop Gastroenterol
; 28(1): 11-5, 2007.
Artigo
em Inglês
| MEDLINE | ID: mdl-17896603
18.
Activated platelets as a possible early marker to predict clinical efficacy of leukocytapheresis in severe ulcerative colitis patients.
J Gastroenterol
; 41(6): 524-32, 2006 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-16868799
19.
Poorly controlled ulcerative colitis treated by colectomy during remission induced by extracorporeal leukocyte removal therapy.
J Gastroenterol
; 38(7): 684-9, 2003.
Artigo
em Inglês
| MEDLINE | ID: mdl-12898362
20.
Detection of specific IgE antibodies to nafamostat mesilate as an indication of possible adverse effects of leukocytapheresis using nafamostat mesilate as anticoagulant.
Ther Apher Dial
; 8(1): 45-51, 2004 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-15128019